Cargando…

Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells

Recently, long non-coding RNAs (lncRNAs) are identified as new crucial regulators of diverse cellular processes, including cell proliferation, differentiation and cancer cells metastasis. Accumulating evidence has revealed that aberrant lncRNA expression plays important roles in carcinogenesis and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, W, Sun, M, Zang, C, Ma, P, He, J, Zhang, M, Huang, Z, Ding, Y, Shu, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917662/ https://www.ncbi.nlm.nih.gov/pubmed/27195672 http://dx.doi.org/10.1038/cddis.2016.126

Ejemplares similares

Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1
por: Luo, Wenzheng, et al.
Publicado: (2019)

Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer
por: Zang, Chongshuang, et al.
Publicado: (2016)

Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer
por: Ding, J, et al.
Publicado: (2017)

Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription
por: Min, Jie, et al.
Publicado: (2022)

The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer
por: Wei, Chen-Chen, et al.
Publicado: (2016)

Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1
por: Xue, Peng, et al.
Publicado: (2021)

The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2020)

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)

Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2022)

Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
por: Hong, Seong Hwi, et al.
Publicado: (2023)

Long non-coding RNA AGAP2-AS1 increases the invasiveness of papillary thyroid cancer
por: Shao, Liang, et al.
Publicado: (2020)

Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity
por: Zheng, Zhongqiu, et al.
Publicado: (2019)

The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3
por: Chen, Jingjing, et al.
Publicado: (2019)

The long non‐coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell
por: Xu, Yetao, et al.
Publicado: (2017)

Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression
por: Shen, Sining, et al.
Publicado: (2020)

Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer
por: Shi, Xuefei, et al.
Publicado: (2018)

LATS2 Positively Regulates Polycomb Repressive Complex 2
por: Torigata, Kosuke, et al.
Publicado: (2016)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes
por: Yang, Jiebin, et al.
Publicado: (2020)

Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma
por: Gao, Lei, et al.
Publicado: (2020)

Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer
por: Ma, Li-cong, et al.
Publicado: (2020)

DJ-1 upregulates breast cancer cell invasion by repressing KLF17 expression
por: Ismail, I A, et al.
Publicado: (2014)

EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Lui, Julian C., et al.
Publicado: (2016)

SP1-induced long non-coding RNA SNHG6 facilitates the carcinogenesis of chondrosarcoma through inhibiting KLF6 by recruiting EZH2
por: Pu, Fei-Fei, et al.
Publicado: (2021)

Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2
por: Huang, Ming-de, et al.
Publicado: (2015)

Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2
por: Huang, Ming-de, et al.
Publicado: (2015)

HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling
por: Hu, Jiao-Jiao, et al.
Publicado: (2016)

SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A
por: Ji, Hao, et al.
Publicado: (2021)

Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation
por: Guo, Yidi, et al.
Publicado: (2015)

Erratum to: Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2
por: Huang, Ming-de, et al.
Publicado: (2017)

SP1 and RARα regulate AGAP2 expression in cancer
por: Doush, Yegor, et al.
Publicado: (2019)

EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
por: Shih, C-H, et al.
Publicado: (2017)

Repression of Igf1 expression by Ezh2 prevents basal cell differentiation in the developing lung
por: Galvis, Laura A., et al.
Publicado: (2015)

Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells
por: Stojic, Lovorka, et al.
Publicado: (2011)

Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer
por: Shi, Xuefei, et al.
Publicado: (2016)

A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer
por: Lian, Yifan, et al.
Publicado: (2017)

Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer
por: Tao, Yao, et al.
Publicado: (2020)

The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update
por: Malagraba, Gianluca, et al.
Publicado: (2022)

Repressing the repressor: Ezh2 mediates macrophage activation
por: Neele, Annette E., et al.
Publicado: (2018)

The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
por: Yu, Jindan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8gmatgcgharg8628bskrivr9dk